galantamine and Central Nervous System Disease

galantamine has been researched along with Central Nervous System Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Curtis, MA; Lin, SX; Sperry, J	1
Aksoz, BE; Aksoz, E	1
Brandt, G; Costantino, HR; Johnson, PH; Leonard, AK; Quay, SC	1
Herrmann, N; Lanctôt, KL; Thompson, S	1
Alekseeva, NV; Bogdanov, IL; Gebesh, VV; Prasolova, GA; Vashchenko, MA	1
Göpel, W	1

Reviews

4 review(s) available for galantamine and Central Nervous System Disease

Article	Year
Pyridine alkaloids with activity in the central nervous system. Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24 Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic	2020
Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology. Combinatorial chemistry & high throughput screening, 2020, Volume: 23, Issue:9 Topics: Central Nervous System Agents; Central Nervous System Diseases; Cholinesterases; Combined Modality Therapy; Donepezil; Drug Design; Enzyme Inhibitors; Galantamine; Humans; Monoamine Oxidase; Rivastigmine; Structure-Activity Relationship; Tacrine	2020
Intranasal administration of acetylcholinesterase inhibitors. BMC neuroscience, 2008, Dec-10, Volume: 9 Suppl 3 Topics: Administration, Intranasal; Alzheimer Disease; Animals; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Galantamine; Humans	2008
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert opinion on drug safety, 2004, Volume: 3, Issue:5 Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome	2004

Trials

1 trial(s) available for galantamine and Central Nervous System Disease

Article	Year
[Nivaline in neurological therapy (report of 100 cases)]. Psychiatrie, Neurologie, und medizinische Psychologie, 1971, Volume: 23, Issue:12 Topics: Adult; Aged; Central Nervous System Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Galantamine; Humans; Injections, Subcutaneous; Male; Neuromuscular Diseases; Paralysis; Peripheral Nervous System Diseases	1971

Other Studies

1 other study(ies) available for galantamine and Central Nervous System Disease

Article	Year
[Etiology, clinical aspects, differential diagnosis and therapy of neurovirus infections]. Vrachebnoe delo, 1974, Volume: 0, Issue:7 Topics: Adenoviridae; Central Nervous System Diseases; Central Nervous System Stimulants; Diagnosis, Differential; Encephalitis; Galantamine; Humans; Meningitis; Meningoencephalitis; Orthomyxoviridae; Physical Therapy Modalities; Respirovirus; Virus Diseases	1974